http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2345766-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8ee484f4ba9a0406b8927b5be6c4f2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9494c30f8f6cb9e15dc21e0d6895855 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
filingDate | 2007-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2009-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f99e05e74eab6792b83e8ff9939c2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22d53fa03a34298f0bfe0718bc632944 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0885438f767d7bd0986ab9a1384c88b |
publicationDate | 2009-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2345766-C1 |
titleOfInvention | Normalisation method of lipid content in thrombocyte membranes associated with metabolic syndrome |
abstract | FIELD: medicine. n SUBSTANCE: correction of lipid composition of thrombocyte membranes in patients suffering from metabolic syndrome (MS) is enabled with three-month individually prescribed hypo-calorie diet, graduated physical activity and preparations Pioglitazone dosed 30 mg once a day, Irbesartan dosed 150 mg once a day and Lerkanidipine dosed 10 mg in the morning. n EFFECT: normalisation of lipid composition of thrombocyte membranes in patients suffering from metabolic syndrome and ensured functioning level specific for healthy people resulted from three-month treatment. n 1 ex |
priorityDate | 2007-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.